Fabry's Disease

What is it? 

Fabry’s disease is a rare genetic disorder caused by mutations in the GLA gene, resulting in deficient activity of the enzyme alpha-galactosidase A (α-Gal A). This enzyme deficiency leads to the accumulation of glycosphingolipids, particularly globotriaosylceramide (Gb3), in various cells and tissues throughout the body. Fabry’s disease primarily affects the kidneys, heart, and nervous system, leading to progressive organ damage and a range of symptoms that can significantly impact quality of life.

What can I do?

1. Genetic Counseling: If you have a family history of Fabry’s disease or are at risk of carrying the gene mutation, consider genetic counseling to understand your risk factors, discuss testing options, and make informed decisions about family planning.
2. Regular Medical Monitoring: Attend regular check-ups with healthcare providers, including specialists familiar with Fabry’s disease, for monitoring of symptoms, assessment of organ function, and management of complications.
3. Enzyme Replacement Therapy (ERT): ERT is a cornerstone of Fabry’s disease treatment, aiming to replace the deficient α-Gal A enzyme and reduce the accumulation of glycolipids in tissues. Adhere to prescribed ERT regimens to help manage symptoms and slow disease progression.
4. Symptom Management: Work with healthcare providers to address specific symptoms of Fabry’s disease, such as pain, gastrointestinal issues, cardiac complications, and kidney dysfunction. Individualised treatment plans may include medications, lifestyle modifications, and supportive therapies.
5. Lifestyle Modifications: Adopt a healthy lifestyle by maintaining a balanced diet, staying physically active, managing stress, getting enough sleep, and avoiding tobacco and excessive alcohol consumption. These lifestyle factors can support overall health and may complement medical treatment for Fabry’s disease.

Common Medical Treatments

1. Enzyme Replacement Therapy (ERT): Recombinant α-Gal A enzyme replacement therapy is the primary treatment for Fabry’s disease, administered intravenously to replace the deficient enzyme and reduce glycolipid accumulation in tissues.
2. Pain Management: Analgesic medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or anticonvulsants, may be prescribed to manage neuropathic pain associated with Fabry’s disease.
3. Cardiac and Renal Care: Treatment for cardiac complications may include medications to manage hypertension, arrhythmias, or heart failure, as well as interventions such as cardiac catheterization or transplantation. Renal care may involve monitoring kidney function, managing proteinuria, and addressing complications such as renal insufficiency or end-stage renal disease.

When to Consult Your Doctor

It is important to consult your doctor if you experience:

• Symptoms suggestive of Fabry’s disease, such as burning pain in the hands and feet, skin lesions, gastrointestinal issues, cardiac abnormalities, or renal dysfunction.
• Family history of Fabry’s disease or genetic risk factors for carrying the GLA gene mutation.
• Concerns or questions about Fabry’s disease diagnosis, treatment, or management.

Remember:

Fabry’s disease is a rare genetic disorder that requires lifelong management and medical monitoring to optimize outcomes and quality of life. By staying informed about the disease, adhering to treatment recommendations, and seeking support from healthcare providers and support networks, individuals with Fabry’s disease can effectively manage symptoms, reduce complications, and lead fulfilling lives.